INVITRO ANTIMICROBIAL SPECTRUM, OCCURRENCE OF SYNERGY, AND RECOMMENDATIONS FOR DILUTION SUSCEPTIBILITY TESTING CONCENTRATIONS OF THE CEFOPERAZONE-SULBACTAM COMBINATION

被引：76
作者：
JONES, RN
BARRY, AL
PACKER, RR
GREGORY, WW
THORNSBERRY, C
机构：
[1] PFIZER PHARMACEUT INC,NEW YORK,NY 10017
[2] CTR DIS CONTROL,ATLANTA,GA 30333
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 1987年 / 25卷 / 09期
关键词：
D O I：
10.1128/JCM.25.9.1725-1729.1987
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1725 / 1729
页数：5
相关论文
共 16 条
[1]   COMPARATIVE ACTIVITY OF BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH BETA-LACTAMS AGAINST BETA-LACTAMASE-PRODUCING ANAEROBES [J].
APPELBAUM, PC ;
JACOBS, MR ;
SPANGLER, SK ;
YAMABE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :789-791
[2]   COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR-830, SODIUM CLAVULANATE, AND SULBACTAM COMBINED WITH AMOXICILLIN OR AMPICILLIN [J].
ARONOFF, SC ;
JACOBS, MR ;
JOHENNING, S ;
YAMABE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) :580-582
[3]   INVITRO SUSCEPTIBILITY OF THE BACTEROIDES-FRAGILIS GROUP TO CEFOPERAZONE, AMPICILLIN, TICARCILLIN AND AMOXICILLIN COMBINED WITH BETA-LACTAMASE INHIBITORS [J].
BARRY, AL ;
JONES, RN ;
PACKER, RR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (01) :125-126
[4]   CEFOPERAZONE - A REVIEW OF ITS INVITRO ANTIMICROBIAL ACTIVITY, PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY [J].
BROGDEN, RN ;
CARMINE, A ;
HEEL, RC ;
MORLEY, PA ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1981, 22 (06) :423-460
[5]   ACTIVITY OF CEFOPERAZONE AND 2 BETA-LACTAMASE INHIBITORS, SULBACTAM AND CLAVULANIC ACID, AGAINST BACTEROIDES SPP CORRELATED WITH BETA-LACTAMASE PRODUCTION [J].
CROSBY, MA ;
GUMP, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (03) :398-405
[6]   CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J].
ENGLISH, AR ;
RETSEMA, JA ;
GIRARD, AE ;
LYNCH, JE ;
BARTH, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :414-419
[7]  
FU KP, 1980, J ANTIMICROB CHEMOTH, V7, P287
[8]   INVITRO ACTIVITY AND DISK SUSCEPTIBILITY OF TIMENTIN - CURRENT STATUS [J].
FUCHS, PC ;
BARRY, AL ;
JONES, RN .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (5B) :25-32
[9]   THE CEFOPERAZONE-SULBACTAM COMBINATION - INVITRO QUALITIES INCLUDING BETA-LACTAMASE STABILITY, ANTIMICROBIAL ACTIVITY, AND INTERPRETIVE CRITERIA FOR DISK DIFFUSION TESTS [J].
JONES, RN ;
BARRY, AL ;
THORNSBERRY, C ;
WILSON, HW .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1985, 84 (04) :496-504
[10]   ANTI-MICROBIAL ACTIVITY OF AMIKACIN COMBINATIONS AGAINST ENTEROBACTERIACEAE MODERATELY SUSCEPTIBLE TO 3RD-GENERATION CEPHALOSPORINS [J].
JONES, RN ;
PACKER, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) :985-989
12